16-1219113-C-A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The NM_021098.3(CACNA1H):​c.6031C>A​(p.Arg2011Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000972 in 1,543,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000093 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0520

Publications

3 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 16-1219113-C-A is Benign according to our data. Variant chr16-1219113-C-A is described in ClinVar as [Benign]. Clinvar id is 2165839.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.052 with no splicing effect.
BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.6031C>A p.Arg2011Arg synonymous_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.6031C>A p.Arg2011Arg synonymous_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.6046C>A p.Arg2016Arg synonymous_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.6016C>A p.Arg2006Arg synonymous_variant Exon 33 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.6013C>A p.Arg2005Arg synonymous_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.6013C>A p.Arg2005Arg synonymous_variant Exon 34 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5998C>A p.Arg2000Arg synonymous_variant Exon 34 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5992C>A p.Arg1998Arg synonymous_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5980C>A p.Arg1994Arg synonymous_variant Exon 33 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5974C>A p.Arg1992Arg synonymous_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.6031C>A p.Arg2011Arg synonymous_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5980C>A p.Arg1994Arg synonymous_variant Exon 33 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5953C>A p.Arg1985Arg synonymous_variant Exon 34 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.6031C>A p.Arg2011Arg synonymous_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.6031C>A non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1950C>A non_coding_transcript_exon_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1079C>A non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3849C>A non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5475C>A non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*972C>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*890C>A non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1610C>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*698C>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*665C>A non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5980C>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.6031C>A non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5998C>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1147C>A non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1950C>A 3_prime_UTR_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1079C>A 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3849C>A 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5475C>A 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*972C>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*890C>A 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1610C>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*698C>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*665C>A 3_prime_UTR_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*1147C>A 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711456.1 linkc.5887+462C>A intron_variant Intron 33 of 33 ENSP00000518769.1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152158
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000755
AC:
11
AN:
145658
AF XY:
0.0000641
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00102
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000935
AC:
13
AN:
1390910
Hom.:
0
Cov.:
34
AF XY:
0.00000584
AC XY:
4
AN XY:
685250
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31470
American (AMR)
AF:
0.00
AC:
0
AN:
35386
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24846
East Asian (EAS)
AF:
0.000337
AC:
12
AN:
35574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
9.30e-7
AC:
1
AN:
1074888
Other (OTH)
AF:
0.00
AC:
0
AN:
57670
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152276
Hom.:
0
Cov.:
34
AF XY:
0.0000134
AC XY:
1
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41542
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 05, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
5.3
DANN
Benign
0.81
PhyloP100
0.052
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs753241781; hg19: chr16-1269113; API